The aim of this study was to test the hypothesis of whether LWE can efficiently prevent MetS and hepatic steatosis, and, if so, to determine the roles that the liver lipogenesis pathway and gut microbiota play in a Lepr−/− rat model. Here, LEPR is linked to metabolic syndrome.